BRAF and colorectal carcinoma: Among stage III resected colon cancer patients treated with adjuvant chemotherapy in a randomized controlled trial (N0147), having a family history of CRC did not impact disease free survival and OS, after adjustment for other predictors of mortality including KRAS or BRAF mutations and MMR status 25.